FDA Inspection 1323474 — Nippon Kayaku Co., Ltd.

Nippon Kayaku Co., Ltd. — FEI 3002807722

The FDA completed an inspection of Nippon Kayaku Co., Ltd. on May 29, 2026 in Takasaki. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 29, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Takasaki (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.